Related Experiment Video
Updated: Jul 13, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Central retinal vein occlusion associated with thrombotic thrombocytopenic purpura/ hemolytic uremic syndrome:
1Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, NE4 9JA, United Kingdom. sharifissa@yahoo.co.uk
We aim to describe a case of central retinal vein occlusion associated with this is a case report of a 45-year-old patient who was admitted for management of thrombotic thrombocytopenic purpura (TTP). He developed left central retinal vein occlusion three months later. The retinal vein occlusion resolved gradually as his TTP started to respond to medical treatment but significant macular edema persisted. Focal argon laser treatment resulted in complete resolution of the macular edema.
We aim to describe a case of central retinal vein occlusion associated with this is a case report of a 45-year-old patient who was admitted for management of thrombotic thrombocytopenic purpura (TTP). He developed left central retinal vein occlusion three months later. The retinal vein occlusion resolved gradually as his TTP started to respond to medical treatment but significant macular edema persisted. Focal argon laser treatment resulted in complete resolution of the macular edema.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Diabetic Retinopathy
Angle Closure Glaucoma: Treatment
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Glaucoma: Overview
